University of Dundee

Latest News for 03/2020

January 2020

March 2019

  • Professor Andrew Hopkins
    21 Mar 2019

    Exscientia, a world leader in artificial intelligence (“AI”) driven drug discovery and a spinout company of the University of Dundee announced today that it has entered a three-year AI drug discovery partnership with leading biopharma company Celgene, including an initial $25 million upfront payment and eligibility to receive substantial milestones based on the clinical, regulatory and commercial success of the program.

January 2019

September 2017

  • 28 Sep 2017

    * EVOTEC INVESTS in Exscientia to advance AI-driven DRUG DISCOVERY Evotec AG and Exscientia Ltd - a company ‘spun out’ from research at the University of Dundee - today announced that Evotec has made a € 15 m investment to take a minority stake in Exscientia. 

July 2017

June 2017

  • Andrew Hopkins and Jérémy Besnard
    20 Jun 2017

    Dundee University spin-out company, Exscientia, won two awards at the Chemistry Means Business 2017 Awards, hosted by the UK Royal Society of Chemistry in Manchester last week. Its Chief Executive Officer Andrew Hopkins has been named Chemistry World ‘Entrepreneur of the Year’ and Chief Technology Officer Jérémy Besnard won the ‘Rising Star in Industry’ Award for their work at Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery. 

May 2017

  • 19 May 2017

    Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce that it has agreed a strategic research collaboration, and licence option agreement with Sanofi in the high-interest area of metabolic disease.  Exscientia is a spin-out company from the School.

November 2016

March 2016

  • 07 Mar 2016

    The Royal Society of Edinburgh has announced today that four people from the University of Dundee have been elected as Fellows of the RSE, three of whom are from the Schools of Life Sciences.   The new Fellows from the University are:   ·         Wendy Alexander, Vice-Principal (International) ·         Paul Birch, Professor of Plant Pathology and Deputy Head of the Division of Plant Sciences

January 2016

  • 20 Jan 2016

    The Universities of Dundee, Oxford and Edinburgh have announced the formation of the Phenotypic Discovery Initiative (PDi) with Janssen Pharmaceutica N.V. the first industry partner joining the initiative.   A phenotype is one or more observable features or traits that report changes in a biological system or its reaction its environment. Phenotypic screening is the systematic identification of agents (such as small molecules, biological molecules or genetic mutations) that alter a phenotype.  

Pages